News | Artificial Intelligence | April 27, 2018

NVIDIA, Canon Medical Systems Partner to Accelerate Deep Learning in Healthcare

Medical imaging vendor teaming with graphics processing unit developer NVIDIA to launch AI solution to mine healthcare data

NVIDIA, Canon Medical Systems Partner to Accelerate Deep Learning in Healthcare

April 27, 2018 — Computer technology company NVIDIA and Canon Medical Systems announced a new partnership to develop the research infrastructure for enhanced artificial intelligence (AI) in healthcare. The partners hope to make a significant contribution to promoting the use of data-intensive deep learning techniques in medical and related research, as well as to drive the uptake of AI in the healthcare sector.

According to NVIDIA, the healthcare sector needs to analyze scientific reports from around the world, while simultaneously coordinating a variety of patient data to determine the most appropriate treatment options. Given the huge volumes of data involved, big data analysis via deep learning will play a major role in the development of optimized healthcare delivery systems and support early detection and assisted diagnosis.

At the same time, medical institutions wanting to use deep learning for independent research need hardware for analysis, systems for the collection, collation and analysis of in-house data, and knowledge of deep learning processes and techniques.

Canon Medical Systems will use NVIDIA DGX systems to process large volumes of medical data generated by Abierto VNA (vendor neutral archive), the proprietary, in-house medical data management system it launched in January.

DGX systems feature NVIDIA Tesla data center graphics processing units (GPUs) powered by the Volta advanced GPU architecture. Among the portfolio is NVIDIA DGX Station, an AI workstation that has the computing capacity of four server racks in a desk-friendly package, while consuming only 1/20 the power.

The systems include NVIDIA’s specially optimized AI software and Canon Medical System’s graphical user interface, which provides full support for the design, deployment and operation of advanced deep learning algorithms.

Deep learning usually requires extensive programming and data science skills. However, the system from Canon Medical Systems and NVIDIA guides users through all the steps involved in the deep learning process, from generating training data with the image viewer to setting up the NVIDIA learning environment.

For more information: www.us.medical.canon

 

Related Content

Collaboration will include data sharing, R&D and an upgrade of RadNet’s fleet of mammography systems to Hologic’s state-of-the-art imaging technology
News | Breast Imaging | August 06, 2020
August 6, 2020 — RadNet, Inc., a national leader in providing hig
Intelerad Medical Systems, a leader in enterprise workflow solutions, announced the acquisition of Radius, a private cloud platform provider based in the Nashville, Tenn., metropolitan area.
News | Enterprise Imaging | August 05, 2020
August 5, 2020 — Intelerad Medical Systems, a leader in enterprise workflow solutions, announced the acquisition of
Keeping the health and safety of of the HIMSS audience in mind, the conference moves to August 9-13 in Las Vegas
News | HIMSS | August 03, 2020
August 3, 2020 —  The Healthcare Informatio...
Candelis, Inc., a leading provider of innovative and cost-effective enterprise healthcare solutions, and VasoTechnololgy, a subsidiary of the Vaso Corporation, announced an agreement to distribute Candelis' suite of image management PACS solutions and cloud services, including ImageGrid, ImageGrid Mini PACS and ASTRA Cloud.
News | Enterprise Imaging | July 29, 2020
July 29, 2020 — Candelis, Inc., a leading provider of innovative and cost-effective enterprise healthcare solutions,
Prostate biopsy with cancer probability (blue is low, red is high). This case was originally diagnosed as benign but changed to cancer upon further review. The AI accurately detected cancer in this tricky case. Image courtesy of Ibex Medical Analytics

Prostate biopsy with cancer probability (blue is low, red is high). This case was originally diagnosed as benign but changed to cancer upon further review. The AI accurately detected cancer in this tricky case. Image courtesy of Ibex Medical Analytics

News | Prostate Cancer | July 28, 2020
July 28, 2020 — A study published in 
Zebra Medical Vision announced its sixth FDA 510(k) clearance for its mammography solution, HealthMammo, which has already received a CE mark. Zebra Medical’s algorithm empowers breast radiologists by prioritizing and identifying suspicious mammograms, providing a safety net for radiologists. The suspicious mammograms are identified faster and read earlier than the current “first-in first-out” standard of care. 
News | Breast Imaging | July 27, 2020
July 26, 2020 —  Zebra Medical Vision announced its sixth FDA 510